Bio-Rad Laboratories (NYSE:BIO.B) Sets New 52-Week High – What’s Next?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $357.05 and last traded at $357.05, with a volume of 332 shares traded. The stock had previously closed at $348.95.

Bio-Rad Laboratories Stock Up 2.3 %

The business’s 50 day simple moving average is $334.34 and its 200 day simple moving average is $326.67. The company has a market capitalization of $10.00 billion, a PE ratio of -13.06 and a beta of 0.72. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.14 and a quick ratio of 4.52.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $2.01 EPS for the quarter. The company had revenue of $649.73 million during the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.